Stop Developing Drugs for the Cancer That Killed My Mother
October 31, 2014
October 31, 2014 Illustration by Shout
Funding drug development for rare cancers can hurt patients.
Scientists need to abandon the assumption that every medical challenge must be overcome by a direct attack.
Click here to continue reading.
Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.
Zebras and giraffes offer one another protection without food competition.